V.F. Corporation returned to organic growth in Q3 after the divestment of Dickies. The earnings turnaround is progressing, but in a volatile manner. VFC's performance varied largely by brand and market as Vans' weakness continues. I estimate VFC stock to have a fair value of $18.3.

Investors need to pay close attention to TBPH stock based on the movements in the options market lately.

Navient's Q4 results benefit from lower expenses and provisions. However, shares slid nearly 10.8% as net interest and other income declined year over year.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gauzy To Contact Him Directly To Discuss Their Options

ATLANTA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether REGENXBIO Inc. (“REGENXBIO” or the “Company”) (NASDAQ: RGNX) complied with federal securities laws. On January 28, 2026, REGENXBIO announced it “received communication from the U.S. Food and Drug Administration (“FDA”) that the Company's Investigational New Drug applications for both its Phase I/II trial evaluating RGX-111 for Mucopolysaccharidosis type I and its Phase I/II/III trial of RGX-121 for Mucopolysaccharidosis type II were placed on clinical hold.” Following this news, the price of the Company's stock dropped.

POET Technologies is positioned as a high-risk, high-reward play in photonic connectivity, benefiting from structural tailwinds and early technology validation. POET's solutions address bandwidth, latency, and energy efficiency challenges in AI data centers, with copper scarcity and soaring prices accelerating photonic adoption. Despite sub-$1M TTM revenue and no major backlog, POET maintains a strong cash runway ($92.7M cash, $7M debt) and successful fundraising history.

NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the “Class Period”), of the important March 9, 2026 lead plaintiff deadline.

Otis Worldwide Corporation (OTIS) Q4 2025 Earnings Call Transcript

M/I Homes, Inc. (MHO) Q4 2025 Earnings Call Transcript

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Klarna To Contact Him Directly To Discuss Their Options

MSCI tops Q4 earnings estimates, and revenues increase more than 10% year over year, but shares slid nearly 5% despite margin expansion.

Apple Inc (NASDAQ:AAPL, XETRA:APC) is set to report its fiscal first-quarter results on Thursday after the bell, with Wedbush expecting a strong performance following the holiday season and growing investor focus on the company's artificial intelligence strategy. Wedbush's Dan Ives believes the market continues to underestimate Apple's longer-term growth prospects, calling 2026 a potential turning point for the company's AI ambitions.

AT&T Inc. (T) Q4 2025 Earnings Call Transcript

Southern Copper Corporation (SCCO) Q4 2025 Earnings Call Transcript

Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call Transcript

More investors will look into Meta Platforms (META) expenses rather than revenue in earnings, says @LikeFolio's Landon Swan. However, he argues the Mag 7 company's revenue can't be ignored.

Kingsoft Cloud (KC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Fastly (FSLY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Commvault Systems (CVLT) shares have decreased by 31% in the past day and are currently priced at $89.13. The sharp drop came after the company's most recent earnings release.

Monte dei Paschi di Siena (MPS) said on Wednesday it had approved rules allowing all of its directors to take part in the process of drawing up a list of candidates for a renewal of the bank's board.